| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.008 | 0.9 |